logo
Intel (INTC) Focuses on Maximizing Operational Cost Savings

Intel (INTC) Focuses on Maximizing Operational Cost Savings

Yahooa day ago
Intel Corporation (NASDAQ:INTC) is one of the 10 Best Semiconductor Stocks to Buy According to Reddit. In Q1 2025, the company's revenue came in at $12.7 billion, flat on a YoY basis. Intel Corporation (NASDAQ:INTC) remains focused on taking a disciplined and prudent approach to support continued investment in its core products and foundry businesses while, at the same time, maximizing operational cost savings as well as capital efficiency. The company has reduced its non-GAAP operating expense target to ~$17 billion in 2025, down from the prior goal of $17.5 billion. In FY 2026, Intel Corporation (NASDAQ:INTC) is targeting $16 billion. Notably, operating expenses consist of research and development (R&D), and marketing, general and administrative (MG&A).
A technician soldering components for a semiconductor board.
Furthermore, the operational efficiencies and better utilization of construction-in-progress assets enable Intel Corporation (NASDAQ:INTC) to reduce the gross capital expenditures target to $18 billion for 2025, down from its previous target of $20 billion. However, the company still expects net capital expenditures of ~$8 billion – $11 billion. Intel Corporation (NASDAQ:INTC) remains focused on investment in its core business as it fuels operational efficiency. Notably, the company's push into the foundry business demonstrates a strong opportunity to diversify the revenue streams as well as capitalize on the elevated demand levels for semiconductor manufacturing capacity.
While we acknowledge the potential of INTC as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.
READ NEXT: 13 Cheap AI Stocks to Buy According to Analysts and 11 Unstoppable Growth Stocks to Invest in Now
Disclosure: None. This article is originally published at Insider Monkey.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Wells Fargo Stock Slides as Bank Lowers Its Outlook for a Key Measure of Profitability
Wells Fargo Stock Slides as Bank Lowers Its Outlook for a Key Measure of Profitability

Yahoo

time17 minutes ago

  • Yahoo

Wells Fargo Stock Slides as Bank Lowers Its Outlook for a Key Measure of Profitability

Wells Fargo (WFC) on Tuesday lowered its outlook for net interest income, a key measure of profitability, sending shares lower in premarket trading. Wells Fargo cut its guidance for 2025 net interest income "to be roughly in line" with its 2024 net interest income of $47.7 billion, from its previous forecast of 1% to 3% growth. Net interest income for the second quarter fell to $11.71 billion from $12.02 billion a year ago—below the $11.84 billion analysts anticipated. The lender reported second-quarter adjusted earnings per share (EPS) of $1.6 on revenue that rose to $20.82 billion from $20.69 billion, above analysts' estimates. The results come after the Federal Reserve last month lifted curbs on the bank's growth imposed seven years ago following a series of scandals, including one where staff set up fake accounts. 'The lifting of the asset cap in the second quarter marked a pivotal milestone in Wells Fargo's ongoing transformation, along with the termination of thirteen consent orders since 2019, including seven this year alone," CEO Charlie Scharf said in a release. Wells Fargo shares, which entered Tuesday up about 19% this year, were down close to 4% in premarket trading. Read the original article on Investopedia Sign in to access your portfolio

Radancy Announces the Next Evolution of Its AI Platform - Redefining How the World Hires with Agentic AI
Radancy Announces the Next Evolution of Its AI Platform - Redefining How the World Hires with Agentic AI

Yahoo

time17 minutes ago

  • Yahoo

Radancy Announces the Next Evolution of Its AI Platform - Redefining How the World Hires with Agentic AI

NEW YORK, July 15, 2025 /PRNewswire/ -- Radancy, the global leader in talent acquisition software, today announced the next evolution of the Radancy Talent Acquisition Cloud – an AI-powered platform that transforms how the world hires. Fueled by Agentic AI and insights drawn from the world's largest talent dataset, with billions of interactions, the platform sets a new standard in intelligent hiring – delivering smarter, more cost-effective strategies, better-fit candidates and measurable impact at every stage of the hiring journey. As candidate expectations, skill demands, budget constraints and workforce dynamics shift rapidly, Radancy's next-generation platform replaces fragmented recruiting processes with a seamless, intelligent and adaptive hiring experience. From the first brand interaction to final application, the platform acts with real-time context and intent – empowering organizations to connect with top talent faster, more precisely and more efficiently than ever before. This is more than an upgrade – it's a transformation. The platform equips recruiters with predictive insights and intelligent automation, delivers highly personalized, conversational candidate journeys and embeds real-time intelligence into every interaction. Features like natural language search, dynamic role previews and context-aware AI agents make hiring decisions easier and more effective across the entire process. "Radancy is ushering in a new era of intelligent hiring – where technology doesn't just streamline the process, it elevates it," said Michelle Abbey, President and CEO of Radancy. "Our platform is engineered to connect the right talent to the right roles at the right time – and deliver business results that matter." Every candidate interaction sharpens its ability to anticipate, adapt and act – bridging employer needs with candidate potential and driving optimized performance through embedded analytics. The result: accelerated hiring cycles, reduced costs, less friction and a more meaningful experience for all stakeholders. Built for global scale, flexibility and results, the Radancy Talent Acquisition Cloud combines deep industry expertise, ethical AI principles and a unified experience across the reimagined hiring journey. Robust data security, compliance and governance are embedded into the core of the platform – ensuring enterprises meet evolving regulatory standards while safeguarding privacy and trust. With an unwavering commitment to support, innovation and ROI, Radancy empowers enterprises to build the workforce of tomorrow – with clarity, confidence and competitive advantage. About RadancyRadancy delivers the future of hiring. As the global leader in talent acquisition software, Radancy helps enterprises strengthen their organizations with an AI-powered platform that simplifies hiring, reduces costs and accelerates results. Fueled by rich data and deep industry expertise, the Radancy Talent Acquisition Cloud transforms every step of the candidate journey to hire the most qualified talent in any environment – driving efficiency, enhancing experiences, maximizing ROI and empowering organizations to build the workforce of tomorrow. Learn more at View original content: SOURCE Radancy Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Wave Life Sciences Unveils Promising Preclinical Data for Obesity Treatment WVE-007 at ADA Scientific Sessions
Wave Life Sciences Unveils Promising Preclinical Data for Obesity Treatment WVE-007 at ADA Scientific Sessions

Yahoo

time17 minutes ago

  • Yahoo

Wave Life Sciences Unveils Promising Preclinical Data for Obesity Treatment WVE-007 at ADA Scientific Sessions

Wave Life Sciences Ltd. (NASDAQ:WVE) is one of the best low priced pharma stocks to buy now. From June 20 to 23, Wave Life Sciences presented preclinical data for WVE-007, which is its investigational GalNAc-siRNA targeting INHBE mRNA, at the American Diabetes Association's 85th Annual Scientific Sessions in Chicago. The oral presentation was delivered on June 21 and highlighted WVE-007 as a potential novel and distinct obesity treatment designed to induce healthy weight loss by reducing fat while preserving muscle mass. WVE-007 functions by silencing INHBE mRNA, which in turn reduces the production of Activin E protein. Activin E is a lipolysis suppressor that is upregulated in obesity. By inhibiting Activin E, WVE-007 promotes lipolysis, or fat breakdown. A biotechnology laboratory filled with computers and equipment to support research. Human genetics provides strong support for INHBE as a therapeutic target. Individuals with a protective loss-of-function variant in one copy of the INHBE gene exhibit a healthier cardiometabolic profile, which includes less abdominal fat, lower triglycerides, and reduced risk of type 2 diabetes/T2D and cardiovascular disease/CAD. These individuals also show favorable associations with liver traits, such as reductions in cT1 (reflecting liver inflammation and fibrosis) and ALT (reflecting liver damage), without impacting liver fat. Wave Life Sciences Ltd. (NASDAQ:WVE) is a clinical-stage biotechnology company that designs, develops, and commercializes ribonucleic acid/RNA medicines through PRISM, which is a discovery and drug development platform. While we acknowledge the potential of WVE as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the . READ NEXT: and . Disclosure: None. This article is originally published at Insider Monkey. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store